While some may argue that the healthcare industry has been a relatively late adopter of information technology (IT), it might be surprising then to learn that the immersive 3D internet, also known as virtual worlds, has made rapid inroads throughout this industry. A virtual world (VW) is a 3D immersive, computer-simulated environment where users are represented by avatars through which they interact in real time with other avatars, objects and the environment. Due to the fast growth of broadband internet access and computing power, individuals and organizations throughout the healthcare ecosystem are “stepping into the internet” and using VWs in areas such as research and development, hospital construction, medical training, sales and marketing, and patient care. VWs offer great promise in transforming healthcare, and the objective of this panel therefore is to introduce VWs and showcase a variety of healthcare applications with the purpose of engaging the audience in a discussion of how VWs can be used in a meaningful manner.
In an effort to generate lively debate and to facilitate an understanding of the topic, the panel will be a mixed reality event, ie the panelists will be located physically in the US and Europe and will present through skype and their avatars. Additionally, we will take the audience on a guided tour of relevant sites in Second Life as well as the virtual worlds of Clinispace and Merck’s custom world built in ProtoSphere by ProtonMedia. The audience will be encouraged to engage in discussing their impressions of what they see.
Here are the panel’s introductory slides.
Dr. Carl Johan Sundberg
Dr. Carl Johan Sundberg is Senior University Lecturer in Bioentrepreneurship and heads the Unit for Bioentrepreneurship at Karolinska Institutet. He is a licensed physician and Associate Professor at the Dpt of Physiology and Pharmacology, where his research group focuses on physical activity and the molecular mechanisms of angiogenesis and mitochondrial biogenesis in human skeletal muscle. He works half-time as investment manager at Karolinska Investment Fund. Apart from educational programmes at UBE, Carl Johan directs several other courses, e.g. Medicine for Journalists, Medicine for Decision Makers and Popular Science Communication for medical and PhD students. He has received the Karolinska Institutet Prize for Teaching Excellence, a Certificate of Commendation for Communication in Life Sciences from EMBO, Ångpanneföreningen’s Prize for Research Communication and the European Commission’s Descartes Communication Prize for Excellence in Science Communication 2005. He is Vice President of Euroscience and was the initiator of Euroscience Open Forum (www.esof2008.org). Sundberg has served as member or chairman of numerous company boards, currently e.g. NsGene A/S, Cellectricon AB and Alfta Rehab AB.
Discipline/field of expertise: Bioentrepreneurship and innovation
Institution/organization/country: Karolinska Institute, Sweden
Dr. Parvati Dev Dr. Parvati Dev has a PhD in Electrical Engineering at Stanford University, has conducted research at M.I.T. and the V.A. on computational biology, and at CEMAX, an imaging company, on 3D medical imaging for surgical planning. At Stanford University, she founded and ran an internationally recognized learning technologies lab, SUMMIT, with numerous firsts in multimedia, web and simulation for medical education. Dr. Dev has received numerous awards including the Satava Award for Medicine Meets Virtual Reality, and the Federal Virtual Worlds Challenge grand prize for Artificial Intelligence in a training product. Dr. Dev is a frequent speaker on the future of technology in learning. Her current focus on experiential learning has led her to start a company which has recently launched a browser-‐based, 3D medical virtual world, CliniSpace (www.clinispace.com).
Discipline/field of expertise: e-learning in healthcare
Institution/organization/country: President, Innovation in Learning Inc. Distinguished Visiting Scholar, Media-X, Stanford University, Former Director, SUMMIT Lab, Stanford University School of Medicine, USA
Dr. Robin Teigland
Dr. Robin Teigland is Associate Professor at the Center for Strategy and Competitiveness at the Stockholm School of Economics (SSE) and the caretaker of SSE’s island in Second Life. Robin’s research interests include how virtual worlds and social media impact the creation and diffusion of knowledge in social networks and the subsequent impact of these knowledge flows on organizational and regional competitive advantage. Robin has published numerous articles and in 2008 she received the “Researcher of the Year” award at SSE. She has participated in EU projects and as a reviewer for the US National Science Foundation. Robin recently led the Nordic Virtual Worlds Network (NVWN), a two-year international project investigating innovation and entrepreneurship through VWs and the 3D internet financed by the Nordic Innovation Center. Robin is a globally sought after speaker on VWs and will present in this panel both an overview of VWs and the VW industry as well as a number of VW applications in the healthcare industry. More information is at www.knowledgenetworking.org.
Discipline/field of expertise: Business Administration
Institution/organization/country: Stockholm School of Economics, Sweden
Dr. Christopher Welch Dr. Christopher Welch is Science Strategy Lead for Global Analytical Chemistry at Merck Research Laboratories. He also chairs the organization that funds the acquisition and evaluation of first into Merck technologies. He researches the development and application of new separation and analysis technologies to facilitate pharmaceutical discovery and development. Chris has BS degrees in Chemistry and Biochemistry and a Ph.D. degree in Organic Chemistry from the University of Illinois at Urbana-Champaign. He has more than 175 publications and patents and is co-founder of Enantiomer. He sits on the editorial boards of Chirality and Chemistry World, the editorial advisory board of Organic & Biomolecular Chemistry, and the Permanent International Scientific Committee for the International Symposia on Chirality. He has several awards, e.g., PACS Activated Carbon Hall of Fame. Chris is a councilor for the American Chemical Society Division of Organic Chemistry and an ACS Fellow.
Discipline/field of expertise: Development and application of new separation and analysis technologies to facilitate the discovery and development of pharmaceuticals
Institution/organisation/country: Merck & Co, Inc., USA
Scott Boyd has been with Merck for over eight years and is currently a Learning Technology Specialist with the Merck Polytechnic Institute. Scott has a Master of Science in Instructional Systems Design as well as a Bachelor of Fine Arts in Communication Design. He has more than ten years of progressive experience in developing, managing, and leading a wide range of learning and development strategies and projects. Scott’s tasks today include identifying training needs, providing e-learning development, consulting, facilitating, coaching and measuring training effectiveness for multiple projects.
Discipline/field of expertise: Development and management of learning and training
Institution/organisation/country: Merck & Co, Inc., USA
Euroscience Open Forum (ESOF)
The Euroscience Open Forum (ESOF) is Europe’s largest, general science meeting and is held in a leading Europe city every two years. ESOF 2012 will be hosted in Dublin from July 11th-15th , 2012. The first meeting was held in Stockholm in 2004, followed by Munich (2006), Barcelona (2008) and Turin (2010). Dublin was awarded the honour of hosting ESOF in 2012, following an open competition. Copenhagen will host then event in 2014.
ESOF is an interdisciplinary, pan-European meeting, held under the auspices of Euroscience, which aims to:
- Showcase the latest advances in science and technology;
- Promote a dialogue on the role of science and technology in society and public policy;
- Stimulate and provoke public interest, excitement and debate about science and technology.
The full ESOF 2012 programme is available online.
If you have any questions, please do not hesitate to contact Robin at robin.teigland<at>hhs.se.